title: Lowering of plasma valproic acid concentrations during concomitant therapy with meropenem and amikacin.
authors.forename: B J
authors.initials: BJ
authors.lastname: De Turck
authors.forename: M W
authors.initials: MW
authors.lastname: Diltoer
authors.forename: P J
authors.initials: PJ
authors.lastname: Cornelis
authors.forename: V
authors.initials: V
authors.lastname: Maes
authors.forename: H D
authors.initials: HD
authors.lastname: Spapen
authors.forename: F
authors.initials: F
authors.lastname: Camu
authors.forename: L P
authors.initials: LP
authors.lastname: Huyghens
mesh_terms: D000368:Aged; D000583:Amikacin / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D000927:Anticonvulsants / Q000097:blood*; D004336:Drug Antagonism; D005260:Female; D006801:Humans; D000077731:Meropenem; D008875:Middle Aged; D013845:Thienamycins / Q000009:adverse effects*; D014635:Valproic Acid / Q000097:blood*
chemical_list: D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D013845:Thienamycins; D014635:Valproic Acid; D000583:Amikacin; D000077731:Meropenem